Latest news
Neurocrine Biosciences Begins Phase 1 Study of GLP-1/GIP/Glucagon Triple Agonist NBIP-'1968 for Obesity - BioPharm InternationalBioPharm International · Fri, 07 Aug 2026 17:19:41 GMTCould GLP-1 Drugs Lower Heart Attack Risk? - Technology NetworksTechnology Networks · Wed, 05 Aug 2026 22:47:00 GMTHow Do GLP-1s Work? Understanding the Mechanism of Action - GoodRxGoodRx · Wed, 05 Aug 2026 07:00:00 GMTGlp 1 Gip Dual Agonists: The Complete Guide To Next Gen Metabolic Health [uEARvOdg1LM] - Diario ASDiario AS · Sat, 01 Aug 2026 19:49:03 GMTGlp 1 Gip Agonists: A Comprehensive Guide To The New Era Of Metabolic Health [X25BTtyEgOV] - Diario ASDiario AS · Sat, 01 Aug 2026 17:15:52 GMTAltimmune rises as GLP-1/glucagon drug curbs heavy drinking in mid-stage study - BioSpaceBioSpace · Tue, 28 Jul 2026 07:00:00 GMT